RFP - supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents for the treatment of haemophilia

Medicines

RFP Closed

PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents (Recombinant Factor VIIa and FEIBA) in New Zealand. 

If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz(external link)).

Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.

This request for proposals (RFP) document incorporates the following schedules:

Full text of RFP [PDF, 257 KB] - supply of products used for the treatment of haemophilia

PHARMAC standard terms and conditions for the supply of pharmaceuticals [PDF, 79 KB]

If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 5:00 pm on Monday, 20 August 2018 - RFx ID 19909881.

If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)).

We look forward to receiving your proposal.